Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs (Q70930163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

title

Changes in serum lipoprotein(a) in hyperlipidemic subjects undergoing long-term treatment with lipid-lowering drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

author name string

A S Dobs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

M Prasad

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

A Goldberg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

M Guccione

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

D R Hoover

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

publication date

1 October 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Drugs and Therapy

14 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

page(s)

677-684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

14 October 2019

cites work

1 reference

12 December 2020

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

1 reference

12 December 2020

Lipoprotein(A): physiologic function, association with atherosclerosis, and effects of lipid-lowering drug therapy

1 reference

12 December 2020

Apolipoprotein(a) polymorphism predicts the increase of Lp(a) by pravastatin in patients with familial hypercholesterolaemia treated with bile acid sequestration

1 reference

12 December 2020

Time course of serum Lp(a) in men after coronary artery bypass grafting

1 reference

12 December 2020

A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol

1 reference

12 December 2020

Lipoprotein(a) and acute-phase proteins in acute myocardial infarction

1 reference

12 December 2020

Lovastatin, pravastatin, and serum lipoprotein(a)

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Transient changes of serum lipoprotein(a) as an acute phase protein

1 reference

12 December 2020

Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia

1 reference

12 December 2020

Serum lipoprotein Lp(a) concentrations are not influenced by an HMG CoA reductase inhibitor

1 reference

12 December 2020

Long-term effect of lovastatin alone and in combination with cholestyramine on lipoprotein (a) level in familial hypercholesterolemic subjects

1 reference

12 December 2020

Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus

1 reference

12 December 2020

Radioimmunoassay of human plasma Lp(a) lipoprotein

1 reference

12 December 2020

Effects of one year of treatment with pravastatin, an HMG-CoA reductase inhibitor, on lipoprotein a

1 reference

12 December 2020

Serum Lp(a) concentrations are unaffected by treatment with the HMG-CoA reductase inhibitor Pravastatin: results of a 2-year investigation

1 reference

12 December 2020

Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia

1 reference

12 December 2020

A prospective study of lipoprotein(a) and the risk of myocardial infarction

1 reference

12 December 2020

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1 reference

12 December 2020

Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment

1 reference

12 December 2020

Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle-aged males

1 reference

12 December 2020

The mysteries of lipoprotein(a)

1 reference

12 December 2020

Lp(a) lipoprotein as a risk factor for myocardial infarction

1 reference

12 December 2020

Confidence limit analyses should replace power calculations in the interpretation of epidemiologic studies

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00878550

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8573550%20AND%20SRC:MED&resulttype=core&format=json

14 October 2019

1 reference